| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |